Hussain A, Tabrez E, Peela J, Honnavar PD, Tabrez SSM
Physiological stimulation was done with static culture in normoxia (21% O 2 )
However, you must disclose all current medications, supplements, digestive aids, and GI treatments to our physicians during consultation
Faster and More Effective Results
The oxidative phosphorylation (OXPHOS) pathway, a main function of mitochondria to generate cellular energy, was markedly upregulated in the AMSCs-treated group (Fig
Weeks 1-4: Initiation Phase Starting dose is low to minimize GI side effects Most patients notice reduced appetite within the first 1-2 weeks Mild nausea is common and typically improves within days Weight loss: 2-5 pounds (mostly water and initial caloric reduction) Key focus: Establish protein intake targets and begin resistance training if not already active Baseline DEXA scan and comprehensive bloodwork completed Months 2-3: Dose Escalation Dose increases every 4 weeks toward therapeutic range Appetite suppression becomes more consistent GI side effects may temporarily recur with each dose increase Weight loss: 1-2 pounds per week typical Patients often report improved energy, better sleep, reduced cravings Follow-up bloodwork to check metabolic markers Months 4-6: Therapeutic Phase Most patients have reached their maintenance dose Steady, consistent weight loss of 1-2 pounds per week Visible changes in body composition and clothing fit Metabolic markers (fasting glucose, triglycerides, HbA1c) typically improving Follow-up DEXA scan to verify fat loss vs
/assets/images/provider/photos/2775923.jpeg)
